Placebo Response Rate in Clinical Trials of Fistulizing Crohn's Disease: Systematic Review and Meta-analysis
Alexander C. Ford(University of Leeds), Walter Reinisch(Medical University of Vienna), Stephen B. Hanauer(Northwestern University), Pavit Luthra(St James's University Hospital), Simon Travis(University of Oxford), M. Scott Harris(Altimmune (United States))
Cited by 23
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes
|Cell Reports|2014|678
Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures
|Cell|2013|603
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
|Gut|2006|603
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558